🇺🇸 US Stock Screener ← Switch market ⚡ HerAI
Financial distress indicators · updated 2026-10-08

PAVmed Inc. — financial distress indicators

PAVM — open full stock page →
HealthcareMedical Devices Mkt cap $26.48MStatements as of Mar 2026 Flows: TTM Mar 2026
82VERY WEAK
Distress score / 100
Statistical model output from public data — not an allegation of insolvency or default. Methodology

Financial-health summary

PAVmed Inc.'s reported numbers place it in the 'Very weak' financial-health band (distress score 82/100). The main indicators are operating profit does not cover interest, market-implied default probability >20% and revenue collapse. Independently, the Ohlson accounting model puts its 1-year failure probability at 82% and the market-implied (Merton) default probability is 46.5%. In its favour: strong current ratio (2.02).

2.02
Current ratio
-1191.55×
Interest cover
—
Debt / EBITDA
12 mo
Cash runway
82%
Ohlson 1-yr PD
46.5%
Merton 1-yr PD
$6.46M
Cash & ST investments
$17.01M
Total debt
-84%
From 52-week high

Stress by dimension

Share price — last 12 months

Indicators behind the score

Each red flag shows the evidence from the company’s own filings and the financial or legal principle behind it. Points add to the 0–100 score.

Operating profit does not cover interest+15
Solvency

Interest coverage (EBIT / interest) is -1191.55×.

When EBIT < interest, debt service is funded from cash reserves or new borrowing — the classic precursor to payment default and covenant breach.

Market-implied default probability >20%+15
Market Signal

Merton distance-to-default 0.09 σ → PD 46%.

Structural (Merton/KMV) model: equity is a call option on assets; low distance-to-default means assets are close to the default point.

Revenue collapse+12
Sales Trend

Revenue changed -98% year over year.

A >30% sales drop typically breaches leverage covenants and starves fixed-cost coverage.

Material debt with no EBITDA+10
Solvency

Debt is 37% of assets while EBITDA is not positive.

With no operating earnings, repayment depends entirely on asset sales or fresh capital.

Share price down >80% from 52-week high+10
Market Signal

Price is -84% from its 52-week high.

Equity markets price distress early; collapses of this size usually reflect fear of wipe-out in a restructuring.

Ohlson O-score signals likely failure+10
Market Signal

O-score 1.54 → model probability 82%.

Ohlson (1980) logit model of 1-year corporate failure; O > 0 (p > 50%) is the original failure cut-off.

Massive shareholder dilution+10
Market Signal

Share count up +149% in a year.

Survival financing: repeated equity raises at depressed prices.

Operating-margin collapse+5
Profitability

Operating margin fell from -2806% to -30127% in two years.

Sharp margin compression signals loss of pricing power or cost control.

Operations consume cash+5
Cash Flow

Operating cash flow negative in 3 of the last 3 years. The company is profitable, so this likely reflects working-capital or loan-book growth.

A business that cannot fund itself from operations depends on external capital to survive.

Revenue vs net income

Cash generation

Debt vs cash vs equity

✅ Mitigating factors

  • Strong current ratio (2.02).
  • High insider/promoter ownership (41%) aligns management with survival.

Frequently asked questions

What do PAVmed Inc.'s financial-health indicators show?

As of 2026-10-08, PAVmed Inc.'s public financial data places it in the 'Very weak' band with a distress score of 82/100, driven by operating profit does not cover interest, market-implied default probability >20% and revenue collapse. This is a statistical screen of reported numbers — it does not mean the company is insolvent, has defaulted or will enter insolvency proceedings.

What is PAVmed Inc.'s financial distress score?

82/100 ('Very weak'). Ohlson O-score 1.54 (model 1-year failure probability 82%). Merton distance-to-default 0.09 σ (model default probability 46.5%).

What works in PAVmed Inc.'s favour?

Strong current ratio (2.02). High insider/promoter ownership (41%) aligns management with survival.

How are shareholders treated if a company enters insolvency?

In a Chapter 11 reorganisation the absolute priority rule pays secured lenders, then unsecured creditors, before shareholders — so existing shares are usually cancelled or heavily diluted. In Chapter 7 the company is liquidated and shareholders rarely recover anything.

Other Healthcare & MedTech companies with distress indicators

All Healthcare & MedTech companies with distress indicators →

Methodology

Score = capped sum of rule-based red flags across seven dimensions (liquidity, solvency, profitability, cash flow, sales trend, market signal, news). Ohlson O-score (1980) gives an accounting-based 1-year failure probability; Merton distance-to-default (Bharath & Shumway 2008) gives a market-implied probability. Financial institutions use a capital-based rule set. Recalculated every trading day from the latest filings, prices and news.

Not a prediction of default or insolvency. This page summarises statistical risk indicators from public data. It does not allege insolvency, default or wrongdoing, and the company may have resources or plans not reflected here (undrawn credit lines, asset sales, parent support, recent capital raises). Verify with the company’s filings (SEC 10-K/10-Q). Not investment or legal advice.